Skip to main content
Equibles

Cornerstone Planning Group LLC

Position in ACXP — Acurx Pharmaceuticals, Inc.

CIK 1822587 FAIRFIELD, NJ
Back to ACXP Full portfolio

Position in ACXP

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$258
-$361 QoQ
Shares Held
167
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 19 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ACXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cornerstone Planning Group LLC holds $333,862 across 45 Biotechnology names. ACXP ranks #44 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 130 $64,574
2 RVMD
Revolution Medicines, Inc.
 199 $37,268
3 HALO
Halozyme Therapeutics, Inc.
 389 $30,447
4 ALNY
Alnylam Pharmaceuticals, Inc.
 97 $29,199
5 RPRX
Royalty Pharma plc
 373 $20,914
6 CRSP
CRISPR Therapeutics AG
 300 $16,362
7 ARGX
Argenx SE
 17 $15,772
8 ABCL
AbCellera Biologics Inc.
 2,000 $15,700

All Filings in ACXP

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $258 167
2026-03-31 $619 167
2025-12-31 $415 167
2025-09-30 $287 67
2025-06-30 $85 167
2025-03-31 $1,304 3,344
2024-12-31 $2,722 3,344
2024-09-30 $6,353 3,344
2024-06-30 $7,524 3,344
2024-03-31 $8,192 3,344
2023-12-31 $12,807 3,344